[QODLink]
Inside Story

Drug firms: protecting profits and products?

Pharmaceutical companies offer controversial new prescription to keep the industry in good health.

Last updated: 29 Apr 2014 18:25
Email Article
Print Article
Share article
Send Feedback

They provide hope for the treatment and cure of countless conditions - from cancer to the common cold. Pharmaceutical companies are also some of the most profitable in the world, and constantly look for new ways to stay competitive.

The US drug maker Pfizer is trying to buy AstraZeneca for close to $100 billion. That would be the industry's biggest-ever takeover.

Valeant is currently offering to buy Allergan - the maker of Botox in a deal worth $48.7 billion. And Novartis has agreed to buy GlaxoSmithKline's cancer drugs for as much as $16 billion, while selling its vaccines division to GSK and its animal health unit to Eli Lilly.

But will it mean more affordable drugs? Is the current recalibration of the pharmaceutical industry a prescription for better healthcare? And how do drug firms balance the need for profit and new products?

Presenter: Hazem Sika

Guests:

Gustav Ando - director of Life Sciences for IHS, and a specialist on mergers and acquisitions

Rohit Malpani - director of Policy and Analysis for Doctors Without Borders' Access Campaign

198

Source:
Al Jazeera
Email Article
Print Article
Share article
Send Feedback
Featured on Al Jazeera
Your chance to be an investigative journalist in Al Jazeera’s new interactive game.
An innovative rehabilitation programme offers Danish fighters in Syria an escape route and help without prosecution.
Street tension between radical Muslims and Holland's hard right rises, as Islamic State anxiety grows.
Take an immersive look at the challenges facing the war-torn country as US troops begin their withdrawal.
Featured
Indonesia's cassava plantations are being killed by mealybugs, and thousands of wasps have been released to stop them.
Violence in Ain al-Arab has prompted many Kurdish Syrians to flee to Turkey, but others are returning to battle ISIL.
Unelected representatives quietly iron out logistics of massive TPP and TTIP deals among US, Europe, and Asia-Pacific.
Led by students concerned for their future with 'nothing to lose', it remains to be seen who will blink first.
Taipei has sided with Hong Kong's pro-democracy protesters as relations with Beijing continue downward spiral.
join our mailing list